• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON & JOHNSON VISION CARE, INC. ¿ IRELAND 1-DAY ACUVUE DEFINE WITH LACREON LENSES, SOFT CONTACT, DAILY WEAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON & JOHNSON VISION CARE, INC. ¿ IRELAND 1-DAY ACUVUE DEFINE WITH LACREON LENSES, SOFT CONTACT, DAILY WEAR Back to Search Results
Catalog Number 1DL
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Corneal Edema (1791); Inflammation (1932); Irritation (1941); Keratitis (1944); Red Eye(s) (2038); Corneal Infiltrates (2231); Discomfort (2330)
Event Type  Injury  
Manufacturer Narrative
(b)(4). (b)(6).
 
Event Description
On 23nov2018 a patient (pt) in (b)(6) reported eye inflammation and was diagnosed with keratitis while wearing the 1-day acuvue define with lacreon brand contact lenses. The eye care provider (ecp) advised the pt not to wear lenses. The pt was prescribed levofloxacin ¿more than 3 times a day¿ but the eye is fine now. Pt thinks the event is due to ¿excess print¿. On 26nov2018 a call was placed to the pt and additional information was provided: the ecp advised the pt to only wear glasses now. The medical report was requested. The event date is reported as (b)(6) 2018. On 06dec2018 the pt¿s medical report was received: date of visit: (b)(6) 2018. Chief complaint: the od was red for 5 days. History: the pt had red eye after wearing contact lens. Pt was diagnosed with keratitis at a hospital and prescribed levofloxacin eye drops, acyclovir eye drops and ganciclovir ointment. Exam od: temporal bulbar conjunctival was ¿hyperaemia¿; ¿there was a white cloudy localized infiltrating lesion in the lower temporal position of the cornea, accompanied by edema¿. Diagnosis: od keratitis. Prescription: sodium hyaluronate eye drops, 1 bottle, od qid; levofloxacin ointment, 1 bottle, od. Notes: follow-up visit after 5 days; stop wearing contact lens; any discomfort, immediately go to the hospital. On 07dec2018 a call was placed to the pt who reported the symptoms have resolved and the pt is currently wearing spectacles. The pt reported possible lasik surgery as pt was told by ecp to avoid wearing contact lenses. On 12dec2018 a call was placed to the pt who reported a ¿few follow-up visits¿ to the ecp. Pt will try to get copies of the medical reports. On 24dec2018 the pts medical report was received: chief complaints: follow-up visit. ¿eye exam: conjunctiva injection, od temporal; 8 o¿clock od corneal white encroaching opacity with edema¿. Diagnosis: keratitis od. Management: routine eye exam; once; anterior segment depth measurement; once; 5ml, 1 bottle, recombinant bovine basic fibroblast growth factor eye drops, qid, 0. 05ml every time. No additional medical information has been received. A lot history review was performed and revealed the following: the batch record did not show any abnormalities in monomer and solution testing. All parameters tested were within specification. All sterilization requirements were successfully completed. Lot 3330590104 was produced under normal conditions. Two open lenses were received in a lens case. The parameters of the two open lenses were measured and a visual inspection was performed. The lenses met company standards for base curve, center thickness, and diameter. A magnified visual inspection revealed both lenses had an edge chip, excess lens material and excess color print. If any further relevant information is received, a supplemental report will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name1-DAY ACUVUE DEFINE WITH LACREON
Type of DeviceLENSES, SOFT CONTACT, DAILY WEAR
Manufacturer (Section D)
JOHNSON & JOHNSON VISION CARE, INC. ¿ IRELAND
one technological park plassey
limerick
EI
Manufacturer Contact
rose harrell
7500 centurion parkway
jacksonville, FL 32256
9044433364
MDR Report Key8256775
MDR Text Key133348913
Report Number9617710-2019-00002
Device Sequence Number1
Product Code LPL
Combination Product (y/n)Y
Reporter Country CodeCH
PMA/PMN Number
N18033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign
Reporter Occupation
Type of Report Initial
Report Date 12/24/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/17/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator
Device Catalogue Number1DL
Device Lot Number3330590104
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/26/2018
Is the Reporter a Health Professional?
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received12/24/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/11/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device?
Type of Device Usage

Patient Treatment Data
Date Received: 01/17/2019 Patient Sequence Number: 1
-
-